HIV/HBV Coinfection
HBV treatment can lead to recovery of virus-specific T-cell responses
Published in Hepatitis Weekly, March 1st, 2004
"Liver-related mortality is an increasing problem in human immunodeficiency virus (HIV)/hepatitis B virus (HBV)-coinfected patients receiving highly active antiretroviral therapy (HAART)," scientists in England noted. "In HIV-negative patients, HBV chronicity is associated with a reduction in specific T-cell responses that can be partially restored by treatment with lamivudine."
R.M. Lascar and colleagues at University College in London examined a group of five "HIV/HBV-coinfected patients treated with HAART, either with or without addition of a drug with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-03-01)
More Articles from Hepatitis Weekly
- Chemotherapy
Lamivudine maintains adriamycin intensity in hepatitis B patients with lymphoma - Psychology
Hepatitis C virus-infected patients with depression tolerate citalopram - Adverse Drug Effects
APOE genotypes may influence a person's response to interferon-alpha - Fatty Liver
Genotype 3 increases the risk for steatosis in those infected with hepatitis C - Proteomics
A newly discovered mimotope could lead the way to HCV receptor antagonism - Public Health
Brazilian ex-soccer players may have spread hepatitis C with shared needles - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
